News & Updates

Show Multimedia Only
Fluvoxamine wins, metformin disappoints in long COVID fatigue
Fluvoxamine wins, metformin disappoints in long COVID fatigue
a day ago byElvira Manzano

The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.

Fluvoxamine wins, metformin disappoints in long COVID fatigue
a day ago
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026 byStephen Padilla

Vaccination against COVID-19 provides survival benefits to cancer patients receiving immune checkpoint inhibitors (ICIs), as shown in a recent study.

COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026